Drug Shortage Report for NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 305)

Last updated on 2019-06-11 History
Report ID 68419
Drug Identification Number 02363658
Brand name NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 305)
Common or Proper name Haemodialysis Solution
Company Name NXSTAGE MEDICAL INC
Active Ingredient(s) SODIUM LACTATE DEXTROSE MAGNESIUM CHLORIDE CALCIUM CHLORIDE POTASSIUM CHLORIDE SODIUM CHLORIDE
Strength(s) 176.5G 23.1G 2.13G 4.63G 1.57G 116.6G
Dosage form(s) SOLUTION
Route of administration DIALYSIS
Packaging size 2 L of concentrate (produces 40 L of dialysate)
ATC code B05ZA
ATC description HEMODIALYTICS AND HEMOFILTRATES
Reason for shortage Other (Please describe in comments)
Anticipated start date 2018-12-05
Actual start date 2019-03-31
Estimated end date Unknown
Actual end date 2019-05-15
Shortage status Resolved
Updated date 2019-06-11
Company comments Low market demand for 2 L size (produces 40 L of dialysate). The same dialysate formulation remains available in a 3 L size (produces 60 L of dialysate)
Health Canada comments
Contact Address 350 MERRIMACK STREET
LAWRENCE, MASSACHUSETTS
UNITED STATES 01843
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2019-06-11 French Compare
v9 2019-06-11 English Compare
v8 2019-02-15 French Compare
v7 2019-02-15 English Compare
v6 2018-12-06 English Compare
v5 2018-12-05 French Compare
v4 2018-12-05 English Compare
v3 2018-12-04 French Compare
v2 2018-12-04 English Compare
v1 2018-12-03 English Compare